Saudi Arabia Drinking Water Market is Projected to Reach US$ 11.26 Billion in 2032, Report By FMI

According to the study, the saudi arabia drinking water market size is estimated to expand at a CAGR of over 7.8% over the forecast period of 2022-2032. Sales in the market are estimated to be valued at US$ 11.26 Billion by the end of 2032

As per Future Market Insights (FMI), bottled water has gained wider acceptability across Saudi Arabia over the years. Consumption of functional drinking water is predicted to increase as instances of problematic/contaminated water supplies remain high. Hence, introduction of bottled water with minerals, vitamins, and flavors is improving the demand in the Saudi Arabia drinking water market.

Growth in the market is underpinned by increased bottled water purchases by the working population in the country to gain more nutrition and safe potable water. Moreover, innovation concerning mobility and portability of bottled water packaging will also the demand for bottled water.

Get Sample of the Report @
https://www.futuremarketinsights.com/reports/sample/rep-gb-15637

As a result, premium bottled water is generally accepted by local customers in the country. It has less sodium and higher mineral content and is packaged in either plastic or glass bottles. It is more expensive than regular bottled water but less expensive than foreign brands, persuading people to develop good habits and use premium bottled water.

Moreover, increased consumption of premium bottled water by restaurants is being observed in the country since it is not common to serve tap water. This is predicted to uplift the demand for premium bottled water over the forecast period.

Key Takeaways from the Saudi Arabia Drinking Water Market Study

  • Online sales segment is the most lucrative sales channel and is expected to witness fastest growth in the market.
  • Based on product type, functional segment is anticipated to account for significant share in the drinking water market.
  • In terms of packaging type, PET bottles are more preferred over plastic bottles to reduce the carbon footprint in the country.
  • By water resources, desalinated seawater and groundwater segment is expected to witness fastest growth over the upcoming decade.

“Key providers in the drinking water market are focusing on increasing their footprint by introducing natural and premium products with a variety of flavors and options. Moreover, they are also investing in marketing strategies to increase the awareness of water hygiene and water consumption.” Says an FMI analyst.

Use promo code ->> FMITODAY to get flat 20% discount

Who is winning?

Leading manufacturers of Saudi Arabia drinking water market are focused on aggressive promotional strategies, advertisements, and new product launches that have driven sales growth of drinking water market in Saudi Arabia.

Major players present in the Saudi Arabia drinking water market are Nestlé S. A., Hayat Water, Al Hada Water Co. Ltd., Naqi Water, Arwa, Dome, Tania, Berain, Al-Qassim Healthy Water, Hana Water, Al Ain Water, Dala Company, Fayha Water, Safawater.qa, Aquafina (PepsiCo, Inc.), Najed, Nova, Manahel, Safa, Mazen, and Al-Manhel, among others.

Saudi Arabia Drinking Water Market by Category

By Product Type:

  • Still Drinking Water
  • Carbonated Drinking Water
  • Flavoured Drinking Water
  • Functional Drinking Water
  • Spring Water

By Water Resources:

  • Surface Water
  • Groundwater
    • Renewable Groundwater
    • Non-renewable Groundwater
  • Non-Conventional Water Resources
    • Desalinated Seawater
    • Treated Wastewater

By Bottle Capacity:

  • 100-300 ml
  • 300-750 ml
  • 1,000-1,500 ml
  • 5,000 ml
  • 15,000 ml
  • 15,000-20,000 ml
  • More than 20,000 ml

By End-User:

  • Commercial
    • Quick Service Restaurants
    • Fine Dining
    • Casual Dining
    • Cafes
    • Bars/Pub
  • Residential

By Packaging Type:

  • PET Bottle
  • Glass Bottle
  • Stand-up Pouches
  • Retort Pouches

By Sales Channel:

  • Direct
  • Indirect
    • Hypermarkets/ Supermarkets
    • Departmental store
    • Convenience Store
    • Online Retailers
    • Drug Stores
    • Other Sales Channel

Ask Our Analyst More About Report @
https://www.futuremarketinsights.com/ask-question/rep-gb-15637

Read Related Report@

https://network-66643.mn.co/posts/35462504?utm_source=manual

https://beyondher.mn.co/posts/35462500?utm_source=manual

https://synkretic.mn.co/posts/35462497?utm_source=manual

https://diigo.com/0sdzzo

About Future Market Insights, Inc.
Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com

U.K. Pet Grooming Market Worth US$ 913.8 Million by 2032 – Exclusive Report by FMI

The U.K. pet grooming market is estimated to expand at a CAGR of over 5.7% throughout the forecast period of 2022-2032, and it is estimated to be valued at US$ 913.8 Million by the end of 2032.

The U.K. pet grooming market is expected to benefit from growing presence of mobile pet grooming salons. These mobile pet groomers provide premium services and also use organic products. Hence, pet owners are willing to invest extensively to ensure that their pets have properly cared for.

Mobile pet grooming salons are the perfect solution for pet owners with busy schedules as they provide particular care to animals and are also handy. For instance, Aussi Pet Mobile is one of the firms that provide mobile pet grooming salons for cats and dogs.

Furthermore, these services save time and are beneficial to both pet owners and pets because they are quick and people do not have to spend time waiting in queues. Additionally, mobile pet grooming services are less expensive than permanent grooming facilities, hence, their popularity among pet owners is expected to rise in the near future.

Request a Sample @
https://www.futuremarketinsights.com/reports/sample/rep-gb-15635

Moreover, mobile groomers offer services at the doorstep, and pet owners are willing to pay for higher service. The portable vans used to provide such grooming services also serve as a marketing medium.

Key Takeaways from the U.K. Pet Grooming Market Study

  • Online sales segment is expected to be the leading segment in terms of sales channel in the U.K. pet grooming market.
  • In terms of product type, shear and trimming tools are likely to generate high demand in the market.
  • Based on pet type, the dog segment will register fastest growth over the upcoming decade.
  • By price range, the US$ 25-US$ 35 segment might witness positive growth in the U.K. pet grooming market

“Key players in the U.K. pet grooming market are focusing on expanding their footprint and increasing sales by releasing natural and luxury products for pets. This would aid in the development of long-term consumer connections in order to retain existing customers and promote brand loyalty.” Says an FMI analyst.

Who is winning?

Leading manufacturers in the U.K. pet grooming market are focused on aggressive promotional strategies, advertisements, and new product launches that have driven sales growth of pet grooming market in the U.K.

Ask an Analyst@
https://www.futuremarketinsights.com/ask-question/rep-gb-15635

Major players present in the U.K. pet grooming market are Beaphar, Spectrum Brands Inc., Company of Animals, Vital Pets, Milly’s, Ferplast S.p.A., Ancol Pet Products Limited, Rolf C. Hagen Inc., The Hartz Mountain Corporation, Groomer’s Choice, Nap Pets (Himalaya Herbal Healthcare), Earthbath, Tecla Company, Synergy Labs, Petco Animal Supplies Inc., and Coastal Pet Products Inc. among others.

U.K. Pet Grooming Market by Category

By Product Type:

  • Conditioner & Shampoo
  • Combs & Brushes
  • Shear & Trimming Tools
  • Others

By Price Range:

  • US$ 5-15
  • US$ 15-25
  • US$ 25-35
  • US$ 35 and Above

By Pet Type:

  • Dogs
  • Cats
  • Birds
  • Fish & Reptiles
  • Small Pets
  • Horses

By Sales Channel:

  • Modern Trade
  • Convenience Stores
  • Care Service Centers
  • Online Retail
  • Support Care Centers
  • Pet Specialty Stores

Ask For Customization@
https://www.futuremarketinsights.com/customization-available/rep-gb-15635

Read Related Reports@

https://shangwich.mn.co/posts/35462513?utm_source=manual

https://stemfemmes.mn.co/posts/35462511?utm_source=manual

https://careero.mn.co/posts/35462509?utm_source=manual

https://thegameoflife-de.mn.co/posts/35462505?utm_source=manual

About Future Market Insights, Inc.
Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com

Brain Tumor Drugs Market is projected to be worth US$ 6.30 billion in 2033 | Get Insights FMI

From 2023 to 2033, the market for drugs for brain tumors is anticipated to grow at a 9.2% CAGR. Market value is anticipated to reach US$ 2.65 billion in 2023 and US$ 6.30 billion in 2033.

The Brain Tumor Drugs Market is likely to grow from US$ 2.65 billion in 2023 to US$ 6.30 billion in 2033.

The Growing Use of Targeted Medicines is Putting a Damper on the Brain Tumor Medications Industry

The purpose of targeted cancer therapy is to kill malignant cells while leaving healthy cells alone. This therapy may be more effective than traditional chemotherapy and radiotherapy because it focuses on changes in the cell that are particular to cancer. Everolimus, for example, is a targeted medication that prevents cancer cells from growing and spreading.

Similarly, unlike chemical medications, which cannot block regeneration, Bevacizumab prevents cancer cell regeneration. The increased popularity of targeted therapy is likely to impact sales of conventional chemical brain tumor medications, limiting market growth over the projection period. Companies in the brain tumor market are concentrating on the application of nanotechnology for innovative treatment.

Get Full PDF Sample Copy of Latest Reports @ https://www.futuremarketinsights.com/reports/sample/rep-gb-16725

Nanoparticles are utilized to deliver medications in combination straight to cancer cells or into tumors. This method has also resulted in a reduction in medicine dosage, increased shelf life, and reduced toxicity. A few nano drugs are proven to be effective in crossing the blood-brain barrier, which has been a substantial obstacle in the treatment of brain malignancies.

A brain tumor is an abnormal mass of tissue in which brain cells grow and replicate in an uncontrollable and fast manner. Brain cancers are classified into two types: primary brain tumors and metastatic brain tumors. Primary brain tumors are those that arise from the brain’s tissues or its surrounding tissues.

Pharmaceutical businesses have improved supply chain management, which has increased research and development and investment in quality control and manufacturing.

Key Takeaways

  • The brain tumor drugs market is expected to record a CAGR of 9.2% during the forecast period 2023 to 2033.
  • The primary drivers of the market are an increase in brain cancer prevalence, the presence of promising pipeline candidates, and an increased need for precision and customized treatment to drive market expansion.
  • North America dominated the brain tumor drugs market.

Ask Analyst for Report Customization and Explore TOC & List of Figures @ https://www.futuremarketinsights.com/ask-question/rep-gb-16725

Key Development in the Brain Tumor Drugs Market

  • April 2021 – MindMed and Nextage Therapeutics signed a Memorandum of Understanding (MOU) to maximize the administration of selected psychedelic drug candidates using Nextage’s unique Brain Targeting Liposome System (BTLS) delivery technology.
  • March 2021 – Roche and GenMark Diagnostics signed a comprehensive merger agreement for Roche to entirely acquire GenMark for US$ 24.05 per share in an all-cash transaction.
  • September 2022 – F. Hoffmann-La Roche Ltd. announced an agreement to acquire Good Therapeutics. With this acquisition, the firm gains access to Good Therapeutic’s platform technology, which is relevant to a wide range of sectors such as cancer, autoimmune illnesses, metabolic disease, and pain management.
  • June 2022 – Novartis AG received the United States FDA approval for Tafinlar + Mekinist for the treatment of paediatric and adult patients with solid cancers containing the BRAF V600E mutation. BRAF mutations are responsible for tumor growth in over 20 different tumor types, including brain, thyroid, and others.
  • November 2021 – Pfizer Inc. purchased Trillium Therapeutics, a clinical-stage immuno-oncology startup focused on creating novel cancer medicines.

Key Segment

By Therapy:

  • Targeted Therapy
  • Chemotherapy
  • Immunotherapy
  • Others

By Indication:

  • Pituitary
  • Meningioma
  • Glioma
  • Others

By Distribution Channel:

  • Hospital Pharmacy
  • Retail & Online Pharmacy

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Cartilage Repair Market is projected to have an effective CAGR of 13.9% from 2022 to 2032 | FMI

The global Cartilage Repair Market is expected to reach a value of US$ 3.9 Bn by 2032, with the market growing at a stellar CAGR of 13.9% from 2022 to 2032. Scaling up from a value of US$ 1.60 Bn in 2021, the target market is set to reach an estimated US$ 1 Bn in 2022. The rising cases of osteoarthritis are fueling the demand for the cartilage repair market during the forecast period.

In the recent past, cases of osteoarthritis have become more prevalent all over the world. As per a report by the University of North Carolina, around one million knee and hip replacement operations are conducted annually in the United States. In the U.S., osteoarthritis cases are accountable for a financial burden of $136.8 Bn per year. A study published by the Arthritis Foundation in 2019 estimated that degenerative joint diseases like osteoarthritis will impact more than 130 million people by 2050.

Get Sample Report + Related Graphs & Charts @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14806

Again, it is expected that the growing cases of osteoarthritis will propel the demand for cartilage repair and regeneration products. The most frequently used treatments for osteoarthritis include autologous chondrocyte implantation and scaffold implants. All of this positively influence the market for cartilage repair. Additionally, as opposed to total knee replacement surgeries, cartilage repair surgeries deliver better and longer-lasting results than other surgeries.

Furthermore, in the past few years, more and more companies are focusing on the development of cartilage regeneration products. This is because governments across the globe are increasing investments in regenerative medicine for cartilage regeneration research. There has also been a surge in clinical trials and the development of new treatments for cartilage regeneration. Besides, the development of a strong pipeline of products based on various methods of cartilage repair available in the market owing to considerable investments in R&D by key market players will further propel the target market growth during the forecast period.

“Increasing osteoarthritis cases coupled with rising demand for treatment will further supplement the global growth of the cartilage repair market over the forecast period,” says an FMI analyst.

Ask Analyst for Report Customization and Explore TOC & List of Figures @ https://www.futuremarketinsights.com/ask-question/rep-gb-14806

Key Takeaways:

  • The high costs of these procedures are expected to restrict the growth of the cartilage repair market.
  • By treatment modalities, the cell-based segment will continue to dominate the global marketplace.
  • On the basis of end-user, the hospital segment will account for the largest market share.
  • The cartilage repair market in the United States will grow at a CAGR of 13.7% during 2022-2032.
  • China’s cartilage repair market will register a CAGR of 13.2% during the assessment period.

Competitive Landscape 

DePuy Synthes, Smith & Nephew plc, Zimmer Biomet, CONMED Corporation, and Stryker Corporation among others are some of the major players in the cartilage repair market profiled in the full version of the report.

Key market participants are focusing on utilizing various organic and inorganic strategies. These firms are investing in research and development activities, introducing new products, and upgrading current ones. Inorganic tactics like mergers, acquisitions, and partnerships are also employed by these businesses.

More Insights into Cartilage Repair Market Report

In its latest report, FMI offers an unbiased analysis of the global cartilage repair market, providing historical data from 2015 to 2021 and forecast statistics for 2022 to 2032. To understand the global market potential, growth, and scope, the market is segmented on the basis of application (hyaline cartilage, fibrocartilage), site (knee, hip, ankle and foot, other application sites), end user (hospitals, ambulatory surgery centers and clinics), and region.

According to the latest FMI reports, based on segmentation, the knee segment is expected to dominate the global marketplace. This segment will contribute considerably to the overall market revenue. This is due to a surge in arthroscopy procedures. In terms of end-user, the hospital segment will lead the global market growth.

Based on region, the cartilage repair market in the United States will present impressive growth over 2022-2032. The target market in this country will register a CAGR of 13.7%. Owing to the rising incidences of bone and joint disorders along with a growing geriatric population pushes the growth of the cartilage repair market in the U.S. In addition, South Korea, China, Japan, and United Kingdom are some of the other countries that demonstrate impressive growth during the forecast period.

Last few days to get reports at discounted prices, offer expires soon!

Request Discount@ https://www.futuremarketinsights.com/request-discount/rep-gb-14806

Key segments

By Application:

  • Hyaline Cartilage
  • Fibrocartilage

By Site:

  • Knee
  • Hip
  • Ankle and Foot
  • Other Application Sites

By End-User:

  • Hospitals
  • Ambulatory Surgery Centres and Clinics

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
LinkedIn| Twitter| Blogs
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Premium Cigarette Market to be US$ 20,330.2 Million by 2032 | Future Market Insights

The global premium cigarette market is expected to be valued at US$ 10,530 Million in 2022. The overall demand for premium cigarettes is projected to grow at a CAGR of 6.8% between 2022 and 2032, totalling around US$ 20,330.2 Million by 2032.

Availability of high quality cigarettes for curious smokers will also drive the sales of Premium cigarette worldwide in the near future. However, stringent government regulations to obtain organic certifications for cigarette and restrictive conditions of the tobacco industry may hamper the growth of the market to some extent.

The availability of premium cigarettes will see significant growth in the long run, owing to the fact that some people are willing to spend more on their smoking habit.

Availability of high quality cigarettes for curious smokers will also drive the sales of premium cigarettes worldwide in the near future.. The availability of Premium cigarettes will see significant growth in the long run, owing to the fact that some people are willing to spend more on their smoking habit.

Request a Report Sample @
https://www.futuremarketinsights.com/reports/sample/rep-gb-13231

What is Driving Demand for Premium Cigarette?

To attract smokers, companies are using organic, natural, and additive-free tobacco labels, which is driving sales of Premium cigarettes. Farmers are also significantly investing in organic farming methods to enhance the crop yield.

Moreover, over the last few years, smokers have shifted their focus towards cigars and cigarettes developed from organic tobacco, creating an opportunity in the Premium cigarette market. In addition to traditional cigarettes, companies are introducing Premium brands with menthol capsules.

These capsules add menthol flavor to cigarettes to improve the tobacco blend. Premium cigarettes with flavor capsules are more popular among youngsters owing to the novelty of smoking some flavored cigarettes.

Covid-19 Pandemic Affected the Sales of Cigarettes and Premium Brands

Because of the unavailability and increased cost of tobacco products, the ongoing covid-19 pandemic has sharply reduced global Premium cigarette sales. Furthermore, tax increases and nationwide lockdowns in various countries are contributing factors to a decline in cigarette and Premium brand sales volume in 2020.

In addition, post the covid-19 pandemic, cigarette sales will be challenged among people who are more health conscious, limited or quit tobacco consumption during the pandemic, and concerned about being infected by coronavirus if they consume tobacco products.

Governments around the world have also increased their awareness programs about the harmful effects of tobacco during the coronavirus pandemic, which may impede market growth to some extent.

However, in order to survive in the market place, companies are improving their strategies and started lowering some of the harmful chemicals used in cigarettes such as tar and nicotine and offering a unique selling proposition to retain their customers.

Additionally, some curious smokers who purchase Premium brands in order to stand out from the crowd are likely to boost Premium cigarette demand over the course of the evaluation period.

China is currently dominating the Global Premium Cigarette Market

More than half of the top cigarette brands sales are generated from Asia-Pacific market. As, cigarette consumption is more associated with low and medium- Human Development Index (HDI) countries. Also, Asian consumers are particularly fond of long-standing, well-reputed and traditional cigarette brands.

China is one of the leading markets for Premium cigarettes globally, as there are around one-third of the world’s total smokers in China. Around 26% of adults aged 15 and above are current smokers in China, which could be the potential customers for Premium cigarette brands in the near future. Moreover, gifting cigarettes and its related products is deeply rooted in Chinese culture particularly in rural areas continues to drive demand for Premium cigarettes. se country’s demand for Premium cigarettes is expected to grow at a significant rate during the assessment period 2021-31, owing to the fact that gifting cigarettes, primarily Premium cigarettes, during holidays or special occasions is a sign of respect and a status symbol among Chinese people.

Demand for Premium cigarettes in China will be led by the male population, as the consumption of tobacco among adult men is significantly higher compared to females.

Who are the Key Manufacturers and Suppliers of Premium Cigarette?

Some of the leading manufacturers and suppliers of Premium cigarette include

  • Reynolds American, Inc.
  • Parliament Hybrid
  • ITG Brands, LLC
  • JTI-Macdonald Corp.
  • British American Tobacco PLC
  • Philip Morris USA Inc.
  • The Nat Sherman Company
  • Gallaher Group
  • Imperial Tobacco Group
  • J. Reynolds Tobacco Company
  • The Chancellor Tobacco Company
  • China Tobacco
  • Thailand Tobacco Monopoly
  • Wilh. from Eicken GmbH

Request For Customization@
https://www.futuremarketinsights.com/customization-available/rep-gb-13231

The smoking experience and tobacco quality are the most important attributes to smokers. Thus, many prominent players in the cigarette market are expanding their product portfolio by significantly investing in premium brands with superior quality, heritage, and more appealing packaging appearance, which makes their Premium brands stand out from mass brands.

Some companies are also creating new smoke-free alternatives and organic flavored tobacco portfolios with fewer or no harmful substances.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments.

Key Segments of Premium Cigarette Market

By Product Type:

  • Flavored
  • Non-Flavored

By Format:

  • Slim
  • Super Slim
  • King Size
  • Regular

By Sales Channel:

  • Specialty Stores
  • Multi-brand Stores
  • Independent Tobacco Shops
  • Online Retailers
  • Others

Request For TOC@
https://www.futuremarketinsights.com/toc/rep-gb-13231

Read Related Reports@

https://faceblox.mn.co/posts/35462523?utm_source=manual

https://drujrake.mn.co/posts/35462522?utm_source=manual

https://nethxt.mn.co/posts/35462520?utm_source=manual

https://network-8702028.mn.co/posts/35462515?utm_source=manual

About Future Market Insights, Inc.
Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com

Retractable Needle Safety Syringes Market is likely to grow at a steady CAGR of 4.0% between 2022 and 2032

[376 Pages Report] As per Future Market Insights’ latest industry analysis, the global Retractable Needle Safety Syringes Market was valued at around US$ 5.49 Bn in 2021 and is anticipated to reach US$ 8.45 Bn by 2032, exhibiting a CAGR of around 4.0% over the forecast period (2022-2032).

Attribute Key Statistics
Retractable Needle Safety Syringes Market Base Value (2021) US$ 5.49 Bn
Projected Market Size (2032) US$ 8.45 Bn
Value-based CAGR (2022-2032) 4.0%
Market Share of Top 5 Countries 53.9%

In the retractable needle safety syringes, as soon as the plunger handle is fully depressed, the needle is immediately drawn back from the patient and into the syringe’s barrel. Pre-removal automatic retraction practically eliminates exposure to the contaminated needle, thus lowering the chance of needle stick injuries.

Get Full PDF Sample Copy of Latest Reports @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15450

Major technological developments related to needles and syringes, such as the introduction of retractable needle safety syringes, lubrication technology and needle-stick safety-equipped devices, have increased the demand for retractable needle safety syringes in the market.

In addition to this, development of various safety devices, such as a passive needle guard with an advanced retractable needle system and plastic shield is largely addressing the issue of needle-stick injuries. Thus, technological advancement will continue to play a key role in spurring growth of the retractable needle safety syringes market.

Furthermore, organizations and manufacturers with advanced procurement functions have opportunity to grow and expand their business to purchasers and traders. Together they work to develop innovative products in order to boost revenues and profits for both parties. They are using different key strategies, such as new product launches, expansion, and collaborations, among others to expand their footprint.

For instance, in June 2021, the space Medtech start-up ResearchSat partnered with the subsidiary of Numedico Technologies Pty Ltd. (Numedico Science Pty Ltd.), to work together for developing innovative therapies and drugs delivery based systems.

Key Takeaways from Market Study

  • By product, manual retractable safety syringes are expected to hold around 1% market value share by the end of 2032.
  • By application, intravenous segment holds a market share value of around 0%.
  • By end-user, hospitals segment accounted for the highest market share value of 7% in 2021.
  • North America accounted for around 4% revenue share of the global retractable needle safety syringes market in 2021.
  • The retractable needle safety syringes market in Germany is set to expand at 1% CAGR during the forecast period.
  • Demand for retractable needle safety syringes in China to increase at a CAGR of 2% over the next ten years.

Ask Analyst for Report Customization and Explore TOC & List of Figures @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-15450

 “With increasing advancement in retractable needle safety syringes and surge in needle stick injury cases, growth in the retractable needle safety syringes market is on the cards,” as per the analyst of Future Market Insights.

Who is Winning?

Acquisition among the companies or brands is the key strategy of the retractable needle safety syringe manufacturers such as Becton, Dickinson and Company, Cardinal Health, and Nipro Corporation to grow their presence in the market and compete with other competitors during the coming years. Following are a few examples of acquisitions made by them to be at the top position:

  • In November 2020, BD acquired the medical business assets of CUBEX LLC, broadening its automated dispensing portfolio across the care continuum.
  • In January 2019, Cardinal Health announced the acquisition of Mirixa Corporation, a leading organization in developing solutions for medication therapy management.
  • In February 2021, Terumo Corporation announced the acquisition of Health Outcomes Sciences, Inc.

Want more insights?

Future Market Insights brings a comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2012 to 2032. The global retractable needle safety syringes market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on retractable needle safety syringes market segment based on Product – (Manual Retractable Safety Syringe and Auto-retractable Safety Syringe), By Application (Subcutaneous, Intramuscular, and Intravenous) By End User – (Hospitals, Clinics, Ambulatory Surgical Centres and Others), By Distribution Channel (Direct to Customer, Retail (Retail Pharmacies and Drug Stores) and Online Pharmacies) across seven major regions.

We Offer tailor-made Solutions to fit Your Requirements, Request Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-15450

Key Players :

  • Axel Bio Corporation, Inc
  • Becton, Dickinson and Company
  • Numedico
  • Lifelong Group
  • DMC Medical Ltd.
  • Retractable Technologies, Inc.
  • Smiths Medical
  • Sol-Millennium Medical Group
  • UltiMed, Inc. (Ulticare)
  • Revolutions Medical Corporation
  • Medicina (HMC Group)
  • Haiou Medical
  • Mediprim
  • Cardinal Health
  • Medline Industries
  • Duopross Meditech Corp.
  • Nipro Corporation
  • Terumo Corporation

Key Market Segments Covered in Retractable Needle Safety Syringes Industry Research

By Product:

  • Manual Retractable Safety Syringe
  • Auto-retractable Safety Syringe

By Application:

  • Subcutaneous
  • Intramuscular
  • Intravenous

By End-User:

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centres
  • Others

By Distribution Channel:

  • Direct to Customer
  • Retail
    • Retail Pharmacies
    • Drug Stores
  • Online Pharmacies

Explore FMI’s Extensive ongoing Coverage on Healthcare Domain

Pancreatic Stone Protein Testing Market Value : The pancreatic stone protein testing market is likely to record a strong CAGR of 1.8% during the forecast period. The pancreatic stone protein testing market is currently valued at US$ 3 Bn in 2022 and is likely to reach US$ 3.59 Bn by 2032.

Multiple Unit Pellet Systems Market Sales : The global multiple unit pellet systems (MUPS) market was valued at US$ 3.48 Bn in the year 2021, expanding at a CAGR of 3.5% to reach an ~US$ 5.07 Bn by the end of 2032.

Humeral Implants Market Volume : The global humeral implants market is likely to be valued at US$ 963.8 Million in 2022. From 2022 to 2032, sales of humeral implants are expected to flourish at a 7.1% CAGR, reaching US$ 2,106 Million.

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Herb & Spice Extracts Market is Forecasted to Surpass US$ 23.9 Billion by the end of 2032 | Future Market Insights Inc.

The herb & spice extracts market is set to witness growth at an average CAGR of 5.1% and is anticipated to reach a valuation of around USD 23.9 Bn by 2032 while it holds a revenue of USD 14.5 Billion in 2022.

FMI’s research report on herb & spice extract market explains that the seeds, stems, and flowers of herbs are used to make herbal extracts. Spice extracts are sweet and pungent and are derived from stems, nuts, berries, barks, and vegetables. Spice and herb extracts have been used in meals and beverages, as well as medications, to impart flavors, colors, and preserve consumer goods.

View our PDF a Sample Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-5055

Herb and spice extracts are also used in packaged food to enhance the flavor. Before adding these herbs and spices to the food, the herbs & spices are processed, distilled, and extracted through multiple temperatures for its wider food applications, pushing the demand for herb & spice extracts.

Increased interest in novel flavors and greater customer awareness of health issues are driving demand for organic spices and herbs. Millennials are very interested in the many flavors and cuisines that reflect regional cultural variations.

The extract and essential oils extracted from these plants are further used in chronic diseases and their prevention. Medicinal use of these herbs and spice extracts fuels the market growth.

Spices and herbs provide customers with numerous health benefits, including lowering blood sugar levels, improving brain function, strengthening immunity, carrying anti-inflammatory properties, and many others. Spices and herb extracts are also an excellent source of key nutrients, making them a significant food component for creating a variety of tasty and nutritious dishes. These natural elements are also responsible for the aroma, flavor, and color of the foods, which will drive the industry for the next few years.

Didn’t find the data you are looking for?
Our experts provide you customized reports! https://www.futuremarketinsights.com/customization-available/rep-gb-5055

Key Takeaways from Market Study

  • Small-scale farmers in locations like the United States, where spices and herb extracts are in high demand, have a lot of trade potential on the market.
  • Shifting client preferences, healthy living practices, and a predilection for Asian cuisines such as Japanese and Chinese are driving the market in Germany.
  • Consumers in China are developing a craving for new and exotic spices and flavors as western foods become more accessible and widespread.
  • Brazil controls the South American market for spices and herb extracts, which are used in a variety of culinary and beverage applications, particularly in bakeries.
  • Increased demand for spices, seasonings, and condiments in food and beverages is likely to fuel segmental growth.
  • Spices and herbs have traditionally been associated with Indian and Chinese cuisines, and they have been used to maintain and improve human beauty.

“Spices and seasonings offer a wealth of medical and physiological benefits. Spices improve the flavor and taste of food and have several health benefits. Antiviral and antibacterial properties, as well as traces of essential nutrients are found in most spices. The future for the herb & spice extracts industry looks promising as people become more health conscious, using extracts for healing. Modern lifestyle has pushed end users to use the organic and natual content present on Eart to use the essential oils it produces for healing and disease prevention. Herb and Spice extracts are growing in popularity due to their high antioxidant content, ability to decrease blood sugar and prevent diabetes, and enhancement of both skin and cognitive performance.” says a Future Market Insights analyst.

Discuss More with Our Experts: https://www.futuremarketinsights.com/ask-question/rep-gb-5055

Competitive Landscape

R&D projects are prioritized by herb and spice extract manufacturers in order to give clients new and enhanced products, helping the herb & spice extract market gain more traction. Companies build partnerships with other manufacturers in order to develop products that will meet their customers’ needs. Manufacturers are also investing heavily in advanced manufacturing technology in order to improve process efficiency while reducing manufacturing costs and time.

  • For example, Synthite Industries Ltd. has included Farmtech, a backward-integrated raw-materials sustainable initiative, to work directly with farmers and ensure the quality of fresh ingredients.
  • Nutrispice is a unique startup that goes through a mixture of ancient wisdom and modern science that creates natural health supplements and ingredients that provides authenticity and originality. This pushes the sales of herb & spice extracts.

Herb & Spice Extracts Market by Category

By Product Type, Herb & Spice Extracts Market is Segmented as:

  • Herb Extracts
  • Spice Extracts

By Form, Herb & Spice Extracts Market is Segmented as:

  • Powder
  • Liquid
  • Others

By Application, Herb & Spice Extracts Market is Segmented as:

  • Food
    • Sauce/dressing/condiments
    • Confectionery/bakery
    • Dairy products
    • Others
  • Beverages
    • Juices
    • RTD Tea
    • Alcoholic beverages
    • Traditional homemade drinks
    • Others
  • Personal Care
    • Skin Care
    • Hair Care
    • Perfumes & Fragrances
    • Aromatherapy
    • Others
  • Nutraceutical
  • Pharmaceutical
  • Others

Buy Now to Gain Access to Detailed Information about Each Segment: https://www.futuremarketinsights.com/checkout/5055

Explore More Valuable Insights

Future Market Insights, in its new report, offers an impartial analysis of the Herb & Spice Extracts market, presenting historical data (2017-2021) and estimation statistics for the forecast period of 2022-2032.

The study offers compelling insights based on Product Type (Herb Extracts, Spice Extracts), Form (Powder, Liquid), Application (Food, Beverages, Personal Care, Nutraceutical, Pharmaceutical), Sales Channel (Direct sales, Indirect sales), across seven major regions of the world.

About FMI

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse Other Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

Germany Oryzenin market is projected to grow at a CAGR of around 3.2% over 2022 to 2032 | Future Market Insights Inc.

The market for oryzenin is anticipated to expand at a CAGR of 7.3% during the anticipated timeframe. According to projections, the market’s worth will rise from US$ 1,040,000 million in 2022 to US$ 2,10,392.6 million by 2032.

“Oryzenin Market: North America to Dominate the Global Oryzenin Market in Terms of Revenue: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2022).” According to the report, oryzenin is a much better alternative as compared to barley, wheat, and rye as it does not lead to any kind of allergies or disorders such as the celiac disease and this is a key factor boosting its demand worldwide.

Consumers seeking lactose free and gluten free source of protein are extensively demanding oryzenin, as it is safe and does not cause any disorders relating to digestion. As per FMI, the global oryzenin market will reach an evaluation of US$12 mn by 2022, expanding it robust CAGR of 7.3% between 2017 and 2022

Check the sample report available in PDF format@ https://www.futuremarketinsights.com/reports/sample/rep-gb-4906

The market for oryzenin is also expected to be boosted by the increasing incidences of gastrointestinal diseases, celiac disease, and irritable bowel syndrome. As the demand for rice protein is increasing on account of its functional properties, the demand for oryzenin will also grow. This is because oryzenin is a glutelin type which is found in the seeds of rice. Some of the other factors impacting the growth of this market include the low cost of producing rice proteins, high protein content, and high gelling properties.

On the basis of geography, the global oryzenin​ market is segmented into Asia Pacific, Europe, North America, and the Rest of the World. Of these, it is estimated that North America will emerge as the most lucrative regional market for oryzenin and expand at a healthy CAGR of 9% between 2017 and 2022. By product type, it is estimated that the isolate segment will lead in the market and expand at a healthy 8.3% CAGR from 2017 to 2022. This segment is also estimated to gain the highest BPS by the end of the forecast period. The report also states that the concentrates segment will exhibit high growth potential in the years to come and exhibit a remarkable CAGR throughout the forecast period.

All these aforementioned factors are the reasons behind the extensive use of oryzenin in the food and beverage industry. The increasing health awareness, use as an enhancer for boosting nutritional value in food products, and growing use in sports nutrition will spur the growth of this market worldwide.

For Getting Your Queries Solve Click@
https://www.futuremarketinsights.com/ask-question/rep-gb-4906

On the basis of form, the dry segment is witnessing high growth rate exhibiting an 8.8% CAGR from 2017 to 2022. The drive segment is estimated to gain the highest VPS by the end of the forecast period. On the other hand, the liquid segment holds high share in the market as compared to the dry segment and this trend is estimated to continue for the rest of the office period.

On the basis of application, the bakery and confectionery segment has witnessed the highest growth rate for oryzenin, closely followed by the sports and nutrition segment. The sports and nutrition segment is estimated to gain high BPS in the years to come. In fact the sports and nutrition segment is not only leading currently but is estimated to continue to do so in terms of revenue through 2022.

The report profiles leading players within the global oryzenin market for the purpose of study. These players are:

  • Kerry Group PLC
  • Aidp Inc.
  • Shenzhen Beike Biotechnology Co. Ltd.
  • BENEO GmbH
  • Axiom Foods, Inc.
  • Ribus, Inc.
  • Golden Grain Group Limited
  • Rice bran Technologies, Inc.
  • Bioway (Xi’An) Organic Ingredients Co., Ltd. and The Green Labs LLC.

Buy Now to Gain Access to Detailed Information about Each Segment: https://www.futuremarketinsights.com/checkout/4906

About FMI

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse Other Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

Chronic Disease Management Market is expected to accumulate a value of US$ 17,267.6 Million by 2032, at a CAGR 13.4% from 2022 to 2032

[Report of 340 Pages] The global Chronic Disease Management Market was worth $4,315.3 million in 2022 and is expected to be worth $17,267.6 million by 2032, growing at a CAGR of 13.4% during the forecast period.

Chronic disease management services are also referred as enhance primary care. This service is provided to the patient suffering from the chronic or terminal health condition and require multidisciplinary care. If any patient suffering from the chronic medical condition such as asthma, COPD, cancer, diabetes, stroke or musculoskeletal diseases for more than six months.

However, there is no specified condition for the patient to provide chronic disease management service. Chronic disease management services are generally provided are long-term care center and rehabilitation center. In chronic care management services patient are aware of the more reliable treatment option. Patient thoroughly guided with to choose appropriate physician and treatment to cure the disease.

This improves the quality of care of patient through various means. Chronic disease management services provider also aware the patient with the available reimbursement scenario provided by Medicare and Medicaid and also guide them to claim the respective allowances. If the patients are opting for chronic disease management service, there is strong possibility that patient will get most appropriate treatment with cheaper price and also get the benefit of allocated reimbursement.

Chronic Disease Management Services Market: Drivers and Restraints

Increasing prevalence of chronic diseases such as asthma, COPD, cancer, diabetes, stroke or musculoskeletal diseases around the globe is the major factor driving the growth of chronic diseases management services market. Beside that increasing awareness of regarding the healthcare management service have also upsurge the growth of chronic disease management services market over the forecast period.

Request a report sample to gain comprehensive insights at https://www.futuremarketinsights.com/reports/sample/rep-gb-5370

Moreover, improved services by service provider have increased the demand for chronic disease management services in the market. The growth in the medical tourism sector and rise in healthcare IT solution have fueled the progression of chronic disease management service market. Inadequate patient engagement and lack of interoperability may responsible for the sluggish growth of this market.

Besides that high investment required to establish the infrastructure and data security concerns related to cloud-based solutions can also hamper the progress of chronic disease management services market.

Chronic Disease Management Services Market: Overview

The chronic diseases management services market is expected show significant growth over the forecast period due to increasing awareness of people.  In 2010 overall spending on chronic diseases management services is 73.6 million. Approximately 36 million people have taken the advantage of Medicare reimbursement policy in 2015 due chronic disease management services.

There is huge competition among the leading services provider in this market. Both leading and local service provider offers various scheme to compete in the market. Chronic disease management service is taking gaining the attractiveness throughout the globe, due to the use of health information technologies and improved availability of the online resource in the healthcare.

Leading services providers of this market are focusing on the collaboration and partnership with healthcare stakeholders to provide patient-centric care.

Chronic Disease Management Services Market: Regional Overview

Based on geographic region Chronic Disease Management Services market is classified into seven key regions, North, America, Latin America, Western Europe, Eastern Europe, APEJ, Japan, Middle East and Africa.  North America is expected to be the most attractive market for chronic disease management service due to the availability of high healthcare infrastructure.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert@ https://www.futuremarketinsights.com/ask-question/rep-gb-5370

This market is then followed by Western Europe and Eastern Europe owing to rising awareness of people in this region. APEJ and Japan are expected to be fastest growing market owing to increasing geriatric population. MEA and Latin America is expected to be the least attractive region for chronic disease management services market due to inadequate patient engagement.

Chronic Disease Management Services Market

 Key Players

Examples of some of the market participants in chronic disease management services market identified across the value chain include, TriZetto Corporation, Phytel Inc., Pegasystems Inc.  EXL Healthcare, AxisPoint Health, Wellcentive, Inc, Medecision, Inc, i2i Systems, Inc., HealthSmart Holdings, Inc., Allscripts Healthcare Solutions, Inc.  ZeOmega Inc. Epic Corporation Inc, and Harmony Information Systems, Inc.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaust analysis on

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain
  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain)
  • Eastern Europe (Poland, Russia)
  • Asia Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

We Offer tailor-made Solutions to fit Your Requirements, Request Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-5370

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Chronic Disease Management Services Market: Segmentation

The global chronic disease management services market is classified on the basis delivery mode, end user, geographic region.

Based on service type, chronic disease management services market is segmented into following:

  • Consulting service
  • Implementation Service
  • Educational Services
  • Other

Based on delivery mode, chronic disease management services market is segmented into following:

  • On Premise
  • Web based
  • Cloud based

Based on end user, chronic disease management services market is segmented into the following:

  • Provider
  • Payer

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Dairy Alternatives Market is Expected to Surpass US$ 47.1 billion by 2033 | Future Market Insights Inc.

The dairy alternatives market was worth US$ 21.2 billion in 2023 and is expected to grow to US$ 47.1 billion by 2033, with an 8.3% CAGR from 2023 to 2033.

Plant-based dairy alternatives’ high nutritional value and functionality profile are expected to be a primary growth driver for the industry forecast. Non-dairy beverages are thought to have higher nutritional qualities than regular milk and milk products. It not only helps lactose intolerant people meet their daily nutritional requirements, but it also helps them fight cholesterol by avoiding animal-based products.

The dairy alternatives market consists of product sales as well as related services. Dairy substitutes are foods and beverages that are used in place of dairy products. These items are derived from plants such as cereals (rice, oats), legumes (soy), seeds (hemp, flax), nuts (peanuts, almonds), and other grains (teff, quinoa).

Download In-depth Report Sample@
https://www.futuremarketinsights.com/reports/sample/rep-gb-4852

Soy milk, rice milk, oat milk, coconut milk, and flaxseed milk are dairy milk replacements; soft cheese and hard cheese are cheese substitutes; and butter substitutes include nut butter, coconut butter, vegetable oil blends, and cultured vegan butter.

Non-dairy milk, butter, cheese, yoghurts, ice cream, and other product categories are the most common product types. Butter is a solid emulsion of fat globules, water, and inorganic salts created by churning cow’s milk cream. Almond, soy, oats, hemp, coconut, rice, and other product types are some dairy replacements. Supermarkets, health food stores, pharmacies, convenience stores, and online businesses sell dairy replacements.

The lack of consumer understanding about the nutritional benefits of dairy replacement products is projected to stymie industry expansion. Many dairy users believe that dairy replacements have less nutrition than cow’s milk and other dairy products. According to the Cargill Study, around 90% of American households utilize dairy products as part of their daily meals, whereas only 4% of the population consumes entirely non-dairy products. As a result, a lack of public understanding about the nutritional benefits of dairy alternatives will stymie industry expansion in the future years.

Talk to Analyst@
https://www.futuremarketinsights.com/ask-question/rep-gb-4852

Key Points

  • The Dairy Alternatives Market is expected to develop at an 8.3% CAGR between 2023 and 2033.
  • More than 80% of Southeast Asians are lactose intolerant, according to the National Institutes of Health.
  • In the dairy substitutes market, the soy category held the biggest share.

Recent Developments

  • In July 2017, SunOpta sold equipment on one of two Lehigh Valley production lines.
  • April 2017 – Danone S.A. (France) was created by WhiteWave Foods Company, an industry entrepreneur. This acquisition will assist Danone S.A in focusing on increasing sales of factory-based products.
  • In December 2019, Nestle’s iconic health-drink brand Nesquik announced the debut of GoodNes, the company’s first plant-based health drink created from a blend of pea protein and oat milk. Nestle claims that its new dairy alternative health beverages have the same nutritional content as regular milk, including 2g of dietary fibre and 6g of protein per cup.
  • April 2022 – Wicked foods, Inc., an American plant-based food manufacturer, revealed its new line of plant-based ice creams and novelty goods.
  • January 2022 – Chobani LLC introduced a new range of four plant-based coffee creamers that are free of GMOs, artificial flavors, and sweeteners.

Didn’t find the data you are looking for?
Our experts provide you customized reports! https://www.futuremarketinsights.com/customization-available/rep-gb-4852

Key Segments Covered in Dairy Alternatives Industry Analysis

By Source:

  • Soy
  • Almond
  • Rice
  • Coconut
  • Oats
  • Others

By Product:

  • Regular/ Unflavoured
    • Soy Milk
    • Almond Milk
    • Coconut Milk
    • Oat Milk
    • Others (Hemp, Flax, etc.)
  • Flavored
    • Soy Milk
    • Almond Milk
    • Coconut Milk
    • Oat Milk
    • Others (Hemp, Flax, etc.)

By Nature:

  • Organic
  • Conventional

By Distribution Channel:

  • Direct Sales/ B2B
  • Indirect Sales/ B2C
    • Hypermarkets/ Supermarkets
    • Convenience Stores
    • Mass Grocery Retailers
    • Specialty Stores
    • Online Retail

About FMI

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse Other Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs